Microangiopathic hemolytic anemia: Difference between revisions
From IDWiki
(Imported from text file) |
(linkified) |
||
| Line 1: | Line 1: | ||
| − | == |
+ | ==Differential Diagnosis== |
| − | * |
+ | *Primary/[[Thrombotic microangiopathy|thrombotic microangiopathies]] (TMA) |
| − | ** |
+ | **[[Thrombotic thrombocytopenic purpura]] (TTP) |
| − | *** |
+ | ***Congenital ([[Upshaw-Shulman syndrome|Upshaw-Shulman]]) |
| − | *** |
+ | ***Acquired |
| − | ** |
+ | **[[Hemolytic uremic syndrome]] (HUS) |
| − | *** |
+ | ***Typical (Shiga-producing [[Escherichia coli]]) |
| − | *** |
+ | ***[[Atypical hemolytic uremic syndrome]] (aHUS) (congenital complement-overactivation) |
| − | * |
+ | *Secondary |
| − | ** |
+ | **[[Antiphospholid antibody syndrome]] |
| − | ** |
+ | **[[Malignant hypertension]] |
| − | ** |
+ | **[[Lymphoma|Lymphomas]] and solid tumours |
| − | ** |
+ | **[[Scleroderma]] crisis |
| − | ** |
+ | **Drug-associated: [[Calcineurin inhibitor|calcineurin inhibitors]], [[quinine]], [[ticlopidine]] |
| − | ** |
+ | **[[Vasculitis]] |
| − | ** |
+ | **Infections: [[HIV]], [[influenza]], [[EBV]], [[parvovirus]] |
| − | ** |
+ | **[[Disseminated intravascular coagulation]] (DIC) |
| − | ** |
+ | **[[HELLP syndrome]] |
[[Category:Hematology]] |
[[Category:Hematology]] |
||
Revision as of 09:04, 2 August 2020
Differential Diagnosis
- Primary/thrombotic microangiopathies (TMA)
- Thrombotic thrombocytopenic purpura (TTP)
- Congenital (Upshaw-Shulman)
- Acquired
- Hemolytic uremic syndrome (HUS)
- Typical (Shiga-producing Escherichia coli)
- Atypical hemolytic uremic syndrome (aHUS) (congenital complement-overactivation)
- Thrombotic thrombocytopenic purpura (TTP)
- Secondary
- Antiphospholid antibody syndrome
- Malignant hypertension
- Lymphomas and solid tumours
- Scleroderma crisis
- Drug-associated: calcineurin inhibitors, quinine, ticlopidine
- Vasculitis
- Infections: HIV, influenza, EBV, parvovirus
- Disseminated intravascular coagulation (DIC)
- HELLP syndrome
